This accessibility statement applies to the Written Medicine web-based application.
This website and application are run by Written Medicine. We want as many people as possible to be able to use our service.
We are committed to ensuring our platform is accessible to users with a wide range of abilities.
The Written Medicine application has been designed to comply with Web Content Accessibility Guidelines (WCAG) version 2.2 Level AA.
Clear and consistent page structure, Logical heading hierarchy
Keyboard navigation
Sufficient colour contrast
Resizable text without loss of functionality
Screen reader compatibility where applicable
Clearly labelled form controls
Plain English content
In addition, the core function of Written Medicine supports accessibility by generating:
Simplified English medication instructions
Multilingual medication labels
Pictogram-enhanced instructions
QR code access to audio guidance
These features support healthcare providers in meeting their obligations under the Accessible Information Standard.
If you find any accessibility problems or need information in a different format, please contact:
Email: info@writtenmedicine.com
We will consider your request and respond as soon as possible.
We are always looking to improve the accessibility of our platform. If you identify an issue, please let us know using the contact details above.
If you are not satisfied with our response, you can contact the Equality Advisory and Support Service (EASS):
www.equalityadvisoryservice.comWritten Medicine is committed to making its web application accessible in accordance with:
The Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018.
The application is designed to comply with WCAG 2.2 Level AA.
Automated accessibility testing tools
Manual keyboard navigation testing
Review of colour contrast ratios
Ongoing usability feedback from healthcare professionals and patients
This statement was prepared on: January 2023
It was last reviewed on: January 2026
Accessibility testing is reviewed periodically as part of ongoing product development and release cycles.